1. In vivo pharmacodynamic activity of a new carbapenem, doripenem, against multiple bacteria in a murine thigh infection model;Andes,2003
2. PK–PD target attainment with Monte Carlo simulation as decision support of Phase 2/3 dosing strategies for clinical development of doripenem;Bhavnani,2003
3. Recent developments in carbapenems;Bonfiglio;Expert. Opin. Investig. Drugs,2002
4. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase;Gales;J. Antimicrob. Chemother.,2003
5. In vitro antimicrobial activity of doripenem, a new carbapenem;Ge;Antimicrob. Agents Chemother.,2004